DAFNA Capital Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $9.69K | Hold |
|
|||||
|
2022
Q3 | $57K | Sell |
|
|||||
|
2022
Q2 | $227K | Hold |
|
|||||
|
2022
Q1 | $500K | Hold |
|
|||||
|
2021
Q4 | $988K | Sell |
|
|||||
|
2021
Q3 | $1.88M | Hold |
|
|||||
|
2021
Q2 | $2.24M | Hold |
|
|||||
|
2021
Q1 | $2.09M | Buy |
|
|||||
|
2020
Q4 | $1.08M | Hold |
|
|||||
|
2020
Q3 | $1.13M | Hold |
|
|||||
|
2020
Q2 | $1.47M | Hold |
|
|||||
|
2020
Q1 | $1.06M | Sell |
|
|||||
|
2019
Q4 | $2.2M | Hold |
|
|||||
|
2019
Q3 | $1.5M | Buy |
|
|||||
|
2019
Q2 | $2.62M | Buy |
|
|||||
|
2019
Q1 | $689K | Sell |
|
|||||
|
2018
Q4 | $309K | Buy |
|